Market Tracker

10/20 5:16pm ET

Hemispherx Biopharma Inc (NYSE American:HEB)

0.325
Delayed Data
As of Oct 20
 -0.005 / -1.52%
Today’s Change
0.30
Today|||52-Week Range
1.15
-52.88%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.33
Today’s open0.33
Day’s range0.32 - 0.33
Volume105,683
Average volume (3 months)309,306
Market cap$10.3M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+52.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-30.83%
P/E ratioNM
Price/Sales163.59
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
ITUSITUS Corp-0.14-5.43%
ARGSArgos Therapeutics I...+0.00+1.45%
RPRXRepros Therapeutics ...+0.13+29.63%
ACHVAchieve Life Science...+0.07+3.60%
Data as of 3:59pm ET, 10/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$92.0K
Annual profit (last year)-$7.5M
Net profit margin-8,154.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts